LEADER 02150nam  2200421z- 450 
001 9910261140003321
005 20231214133221.0
035   $a(CKB)4100000002484692
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/54524
035   $a(EXLCZ)994100000002484692
100   $a20202102d2017      |y             0
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aNeuropeptides and Behaviour: From Motivation to Psychopathology
210   $cFrontiers Media SA$d2017
215   $a1 electronic resource (146 p.)
225 1 $aFrontiers Research Topics
311   $a2-88945-307-3 
330   $aThe discovery of the involvement of neuropeptides with behaviours other than regulatory motivated ones took place in the midst of 1960?s with David de Wied?s first report on the influence of pituitary peptides on memory. This major scientific breakthrough opened a new frontier of studies in Endocrinology and its related fields, Neuroendocrinology and Psychoneuroendocrinology. Neuropeptides were initially thought to be involved in homeostatic regulation and secreted only from neurons located in the hypothalamus; they are now recognized neurotransmitters, produced in and secreted from distinct brain areas, associated with a myriad of, not only, motivated, but also psychopathological behaviours. Motivated behaviours are determinant for individual and species survival, but their expression in a large spectrum and deviations from average may give rise to a number of psychiatric conditions.
517   $aNeuropeptides and Behaviour
610   $adrug adiction
610   $asleep
610   $astress
610   $aanxiety
610   $astress resilience
610   $aNeuropeptides
610   $aadaptive behaviours
610   $afeeding behaviour
610   $adepression
700   $aCarol F. Elias$4auth$01277578
702   $aDeborah Suchecki$4auth
906   $aBOOK
912   $a9910261140003321
996   $aNeuropeptides and Behaviour: From Motivation to Psychopathology$93011660
997   $aUNINA